PHA — Pharmacy
Issues related to general compounding.
Lobbyists: EUGENIA PIERSON; SONJA NESBIT; BOBBY MCMILLIN; CASEY BROUHARD; MICKAYLA STOGSDILL; LUKE ALBERT; MARK EPLEY
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
1e1edd44-f977-4769-ab3f-35b868ed94d3- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-17 18:44:22
- Income (reported)
- $80,000
- Expenses (reported)
- —
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
ARNOLD & PORTER KAYE SCHOLER LLP
Law firm
- Contact
- NICHOLAS TOWNSEND
- Phone
- +1 202-942-5249
- Address
- zip:20001, city:Washington, state:DC, street:601 Massachusetts Ave. NW
Client
Pharmaceutical company.
- State
- NJ
- Country
- US
- Effective date
- 2023-05-01
Issues lobbied + lobbyists
HCR — Health Issues
Issues related to the clinical and overall benefit of anti-obesity medications. Issues related to insulin pricing/affordability. Issues related to general compounding.
Lobbyists: EUGENIA PIERSON; SONJA NESBIT; BOBBY MCMILLIN; CASEY BROUHARD; MICKAYLA STOGSDILL; LUKE ALBERT; RON KIND; MARK EPLEY
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2025 (H.R. 4231 / S. 1973).
Lobbyists: EUGENIA PIERSON; SONJA NESBIT; BOBBY MCMILLIN; CASEY BROUHARD; MICKAYLA STOGSDILL; LUKE ALBERT; RON KIND
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
CSP — Consumer Issues/Safety/Products
Issues related to general compounding.
Lobbyists: EUGENIA PIERSON; SONJA NESBIT; BOBBY MCMILLIN; CASEY BROUHARD; MICKAYLA STOGSDILL; LUKE ALBERT; MARK EPLEY
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE